PMID: 9182821Jun 1, 1997Paper

T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas

The Journal of Investigative Dermatology
M A LowesG M Halliday

Abstract

Spontaneous tumor regression, which is observed clinically and histologically in some primary melanomas, occurs in the absence of any effective therapy. It is probably immunologically mediated, because regressing melanomas are infiltrated with larger numbers of activated T cells, primarily CD4+, than nonregressing melanomas. To investigate the hypothesis that spontaneous regression of melanomas is caused by T-cell cytokine production, cytokine mRNA expression in 20 primary melanomas was examined using a noncompetitive, quantitative reverse-transcriptase polymerase chain reaction method. DNA standards were used to generate known numbers of molecules in each sample. Results were standardized to the internal control, glyceraldehyde-3-phosphate dehydrogenase. mRNA for CD35, lymphotoxin (TNF-beta), and IL-2 were significantly elevated in the ten regressing melanomas compared to the ten nonregressing melanomas. IFN-gamma mRNA was also elevated in regressing melanomas but failed to reach statistical significance. The Th2 cytokines IL-10 and IL-13 did not show differences in the regressing melanomas compared to nonregressing melanomas; neither did the pro-inflammatory cytokines IL-1alpha, IL-1beta, IL-6, IL-8, and TNF-alpha, nor the gr...Continue Reading

Citations

Jun 19, 2001·International Journal of Cancer. Journal International Du Cancer·S MocellinF M Marincola
Oct 31, 2002·Immunology and Cell Biology·Scott N Byrne, Gary M Halliday
Sep 25, 2003·International Journal of Cancer. Journal International Du Cancer·Fabien SaintDominique K Chopin
Jul 5, 2005·Expert Opinion on Investigational Drugs·P A Philip
Jul 5, 2005·Expert Opinion on Investigational Drugs·M J PerryA G Dalgleish
May 20, 2008·Cancer Immunology, Immunotherapy : CII·Lazar VujanovicLisa H Butterfield
Dec 7, 2013·Expert Review of Clinical Immunology·Ryan M TrowbridgeDevendra K Agrawal
Oct 6, 2020·Frontiers in Immunology·Fabienne MaibachMirjam Schenk
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R E CurielI Espinoza-Delgado
Sep 10, 2003·International Reviews of Immunology·Markwin P VeldersW Martin Kast
Sep 24, 2004·Annals of Surgical Oncology·Miguel-Angel Perales, Jedd D Wolchok
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evgeny Yakirevich, Murray B Resnick
Jul 17, 2003·International Journal of Cancer. Journal International Du Cancer·Scott N Byrne, Gary M Halliday
Jul 25, 2000·The British Journal of Dermatology·D A WongG M Halliday
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P TerheydenJ C Becker
Jun 30, 2006·Expert Opinion on Biological Therapy·Christian A PetrulioHoward L Kaufman
Aug 11, 2005·Current Oncology Reports·Christian H PoehleinBernard A Fox
Mar 21, 2008·Photochemistry and Photobiology·Gary M Halliday, J Guy Lyons
Sep 12, 2015·International Journal of Cancer. Journal International Du Cancer·Jiansheng XieWeidong Han
Jun 1, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Annette PflugfelderUNKNOWN German Society of Dermatology
Dec 5, 2016·Biochemistry. Biokhimii︠a︡·A V Bogolyubova, P V Belousov
May 11, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J Xiang, T Moyana
Aug 5, 2000·Drugs & Aging·M J PerryA G Dalgleish
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca C TaylorMary S Brady
Feb 1, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ping Yu, Yang-Xin Fu
Sep 28, 2013·Journal of Cancer Research and Clinical Oncology·Nikolaos KoufosNikolaos Tsavaris
Feb 10, 2000·Springer Seminars in Immunopathology·M R ShurinM T Lotze
May 13, 2005·Cancer Immunology, Immunotherapy : CII·William Chad CragunCraig L Slingluff
Dec 16, 2010·The British Journal of Dermatology·F AntonicelliP Bernard
Jan 7, 2017·Oncotarget·Huafeng WangLinjing Zhang
Aug 24, 1999·Medical Oncology·F Salazar-Onfray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.